Financial Market Update: Crude Oil and Summit Therapeutics Shares Stocks Take a Hit as Crude Oil Slides and Summit Therapeutics Shares Plummet

By: Alex Freidmen

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 200 points on Tuesday.

The Dow traded down 0.18% to 38,557.86 while the NASDAQ fell 1.30% to 15,570.84. The S&P 500 also fell, dropping 0.73% to 4,969.26.

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.

Check This Out: Top 4 Tech Stocks That May Crash This Month

Market Sector Performance

Consumer staples shares rose by 1.2% on Tuesday.

In trading on Tuesday, information technology shares fell by 1.8%.

Top Financial News

The Conference Board’s Leading Economic Index fell 0.4% for January, versus market expectations for a 0.3% decline.

Stocks Making Gains

Monopar Therapeutics Inc. MNPR shares shot up 90% to $0.6472 after the company announced it received Human Research Ethics Committee clearance in Australia to commence a Phase 1 dosimetry trial of its novel radiopharmaceutical MNPR-101-Zr.

Shares of Biofrontera Inc. BFRI got a boost, surging 68% to $1.25 after the company announced a private placement of up to $16 million priced at the market per Nasdaq rules. Biofrontera ALSO announced restructuring of supply agreement with Biofronter AG.

TRxADE HEALTH, Inc. MEDS shares were also up, gaining 94% to $8.04. TRxADE HEALTH announced the sale of assets of subsidiary Trxade, Inc. to Micro Merchant Systems for $22.5 million, with potential additional $7.5 million payout.

Stocks Facing Declines

RAPT Therapeutics, Inc. RAPT shares dropped 71% to $7.53 after the FDA verbally notified clinical hold on the company’s Phase 2B trial of zelnecirnon in atopic dermatitis and Phase 2A trial in asthma.

See also  Progress in Israel-Hamas Ceasefire Negotiations Amidst Sticking Point Progress in Israel-Hamas Ceasefire Negotiations Amidst Sticking Point

Shares of Summit Therapeutics Inc. SMMT were down 28% to $3.6505 after reporting fourth-quarter results.

Fluor Corporation FLR was down, falling 11% to $37.26 following fourth-quarter results.

Commodities

In commodity news, oil traded down 1.9% to $77.72 while gold traded up 0.7% at $2,039.10.

Silver traded down 1.5% to $23.12 on Tuesday while copper rose 0.6% to $3.8620.

Eurozone Update

European shares closed mixed today. The eurozone’s STOXX 600 fell 0.10%, London’s FTSE 100 fell 0.12% while Spain’s IBEX 35 Index rose 0.94% The German DAX fell 0.14% French CAC 40 rose 0.34% while Italy’s FTSE MIB Index rose 0.08%.

Construction output in the Eurozone increased 1.9% from the prior year in December, recording the sharpest surge since February. The current account surplus in the Eurozone rose to €42.66 billion in December compared to €16.62 billion in the year-ago period. Passenger car registrations in the European Union jumped 12.1% year-over-year to 851.7 thousand units in January.

Asia Pacific Markets

Asian markets closed mostly higher on Tuesday, with Japan’s Nikkei 225 falling 0.28%, Hong Kong’s Hang Seng Index rising 0.57%, China’s Shanghai Composite Index gaining 0.42% and India’s S&P BSE Sensex gaining 0.5%.

Hong Kong’s unemployment rate came in unchanged at 2.9% in the three months ending January.

Economic Indicators

US leading index fell 0.4% for January, versus market expectations for a 0.3% decline.

Now Read This: Starbucks, Regeneron Pharmaceuticals And 2 Other Stocks Insiders Are Selling